Wolf Group Capital Advisors Astrazeneca PLC Transaction History

Wolf Group Capital Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 23, 2018	SELL	$34.76 - $39.72 $883,912 - $1.01 Million	-25,429 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$34.55 - $37.05 $106,103 - $113,780	3,071 Added 13.74%	25,429 $893,000
Q1 2018 Apr 25, 2018	BUY	$32.97 - $36.63 $77,809 - $86,446	2,360 Added 11.8%	22,358 $782,000
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $73,261 - $79,402	2,283 Added 12.89%	19,998 $694,000
Q3 2017 Oct 23, 2017	SELL	$28.96 - $34.0 $71,647 - $84,116	-2,474 Reduced 12.25%	17,715 $614,000
Q2 2017 Aug 09, 2017	BUY	N/A	20,189	20,189 $688,000

1,356

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Wolf Group Capital Advisors with notifications on news.